Clinical trial Recruiting at 3 sites Interventional Ages 50 to 100

Developing a digital health program for bladder health in older adults

Official title: On Any Page, Select Quit to Stop Entering Data. Data Entered on Previous Pages Will be Retained: To Complete Data Entry Later, Open the Record From the Home Page

Run by University of Vic - Central University of Catalonia · NCT06583733 · Data updated 2026-11-12

This study is testing a new digital health program to improve bladder health for adults aged 50 and older by getting feedback from users and health experts.

More Urinary Incontinence in Old Age trials

Quick facts

Study typeInterventional
Ages50 Years to 100 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Vic - Central University of Catalonia
Academic / other
Locations4 sites (Kaunas and 3 other locations)
StatusRecruiting
StartedMarch 24, 2025
Main results expectedAugust 31, 2027
Study endsOctober 1, 2028
Registry record updatedMarch 30, 2025
Trial IDNCT06583733 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 50 and over who experience urinary incontinence and have access to a mobile device.

Probably not a fit

Patients with unstable health conditions or red-flag symptoms such as bleeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The KOKU Bladder initiative aims to create and evaluate a digital health program designed to enhance bladder health among adults aged 50 and older. Utilizing a participatory approach, the program will be co-developed with input from end-users, health professionals, and researchers across multiple countries, including Lithuania, Spain, and the UK. The project will involve focus groups to gather insights and preferences, followed by the implementation of a randomized controlled trial to assess the program's feasibility and acceptability. A mixed methods approach will be employed to analyze both quantitative and qualitative data.

Why it matters

Potential benefit: If successful, this program could significantly improve bladder health management and quality of life for older adults experiencing urinary incontinence.

How similar studies have gone: Other studies have shown promise in using digital health solutions for managing urinary incontinence, indicating that this approach has potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥50 (range used in the literature covering the late-life process, including prostate issues and the perimenopause period)
* Self-reported UI (at least 1 leakage/month)
* Ability to read and understand the national languages
* Have a mobile phone/tablet
* Sign informed consent.

Exclusion Criteria:

* Red-flag symptoms (e.g., bleeding)
* Unstable health conditions.

Where it's running

  • Lithuanian Sports University
    Kaunas, Lithuania
    Recruiting
  • Hospital Santa Maria
    Lleida, Spain
    Recruiting
  • Hospital Consortium of Vic
    Vic, Spain
    Recruiting
  • University of Manchester
    Manchester, United Kingdom
    Not yet recruiting

Study contacts

  • Principal investigator: Jerez-Roig, PhD — University of Vic-Central University of Catalonia; Lithuanian Sports University
  • Study coordinator: Javier Jerez-Roig, Professor, PhD
  • Email: javier.jerez@uvic.cat
  • Phone: +34 93 881 60 25

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.